I didn't make it to this year's J.P. Morgan Healthcare Conference in San Francisco, so I reached out to leaders from across the industry to hear how it went and learn about their takeaways from the event. This is a list of the nine most interesting responses that I received.
Chetu is transforming healthcare with AI-driven solutions for greater efficiency and patient care. We provide custom healthcare software solutions & support services to the entire healthcare spectrum. Learn More.
Provider network teams need a better way to streamline healthcare delivery and amplify provider satisfaction. Unlocking value with provider network operations means a forward-looking, fresh approach and the right tools that deliver in four essential areas:
Dyne Therapeutics recently reported encouraging Phase 1/2 clinical data in myotonic dystrophy type 1 and Duchenne muscular dystrophy. At the J.P. Morgan Healthcare Conference, CEO Joshua Brumm said Dyne's existing cash combined with the new capital is expected to last through 2025—well beyond the next key milestones for both therapeutic candidates.
In this episode, we're joined by Dr. Bruce Dorr, an OB-GYN. Dorr discusses how the lack of medical training for menopause has led to insufficient treatment.
Kevin Sayer would love to bring his company's Dexcom G7 continuous glucose monitor to more people and more quickly. But despite being CEO of a successful device company, he feels frustrated from time to time about how and what the U.S. health system will pay for.
No comments